abstract disclosed are compounds having enhanced potency in modulation of nmda receptor activity. such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and / or reducing neuropathic pain. orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed. -------------------------------------------------- -------------------------------------------------- -------- translation of the abstract patent summary: "nmda receptor modulators and uses thereof". Compounds having enhanced potency in modulating nmda receptor activity are disclosed. Such compounds are contemplated for use to treat diseases and disorders, such as learning, cognitive activities and analgesia, particularly alleviating and / or reducing neuropathic pain. Orally available formulations and other pharmaceutically acceptable forms of delivery of the compounds, including intravenous formulations, are also disclosed.abstract disclosed are compounds having enhanced potency in the modulation of nmda receptor activity. such compounds are contemplated for use in the treatment of diseases and disorders, such as learning, cognitive activities, and analgesia, particularly in alleviating and/or reducing neuropathic pain. orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed. ------------------------------------------------------------------------------------------------------------ tradução do resumo resumo patente de invenção: "moduladores de receptor de nmda e usos dos mesmos". são divulgados compostos tendo potência intensificada na modulação da atividade do receptor de nmda. tais compostos são contemplados para uso para tratar doenças e distúrbios, tal como a-prendizagem, atividades cognitivas e analgesia, parti
